Morria Biopharmaceuticals Plc is a British unlisted public company subject to all the relevant Financial Rules & Regulations and registered with Companies House.

• Morria Plc has a USA subsidiary, Morria Biopharmaceuticals Inc., incorporated in Delaware and based in New York City .
• Morria is independently audited on an annual basis and is subject to the same rules and regulations as any public limited company in the UK. Morria is both EIS and VCT compliant.
• Round A (Feb 2005) raised £2.1m via a POS at £0.60 p/share at a post-money valuation of £7m.
• Round B (Mar 2007) raised £1.6m via a POS at £0.80 p/share at a post-money valuation of £13m.

For more information, please visit our contact page